LabCompass

Publications

78

Citations

1,622

Est. group size

~7

Recurring co-author estimate

Active years

29

Publishing since 1998

Research summary
AI-generated

Longhua Sun's recent research focuses on lung cancer, particularly non-small cell lung cancer (NSCLC) and lung adenocarcinoma. The work spans clinical trials of new drugs (such as antibody-drug conjugates and targeted therapies), laboratory studies of the molecular pathways that drive cancer growth, and the development of diagnostic methods for detecting cancer markers. Studies often examine how specific proteins and signaling pathways influence tumor progression and treatment response.

Lung cancer therapy and clinical trialsCancer molecular signaling pathwaysAntibody-drug conjugates and targeted treatmentsCancer biomarker detection and diagnosticsTumor immunotherapy

Publication activity has been fairly steady over the past decade with a notable increase in the most recent years, peaking in 2025.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.8/year recently
2017: 3 publications172018: 3 publications182019: 10 publications192020: 4 publications202021: 5 publications212022: 4 publications222023: 5 publications232024: 6 publications242025: 13 publications13252026: 1 publication26
Recent publications
Publishes in
  • Journal of Clinical Oncology×3
  • Pathogens×3
  • Insects×3
  • Research Square×3
  • Nature Communications×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile